PSB-12062
| PSB-12062 | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
PSB-12062 is a chemical compound that acts as a selective antagonist of the adenosine A2B receptor. It is primarily used in research settings to study the physiological and pathological roles of the A2B receptor, which is involved in various processes such as inflammation, cancer, and cardiovascular diseases.
Pharmacology[edit]
PSB-12062 exhibits high affinity and selectivity for the adenosine A2B receptor, which is one of the four subtypes of adenosine receptors. These receptors are G protein-coupled receptors that mediate the effects of adenosine, a purine nucleoside that plays a crucial role in biochemical processes such as energy transfer and signal transduction.
Mechanism of Action[edit]
As an antagonist, PSB-12062 binds to the A2B receptor and inhibits its activation by adenosine. This blockade can modulate various downstream signaling pathways, including the inhibition of adenylate cyclase activity, reduction of cyclic AMP levels, and alteration of protein kinase A activity. These effects can influence cellular responses such as vasodilation, immune cell activation, and tumor progression.
Therapeutic Potential[edit]
Research into PSB-12062 and other A2B receptor antagonists is ongoing, with potential therapeutic applications in conditions such as:
- Asthma and Chronic Obstructive Pulmonary Disease (COPD): By reducing inflammation and bronchoconstriction.
- Cancer: By inhibiting tumor growth and metastasis.
- Cardiovascular diseases: By modulating vascular tone and reducing ischemic injury.
Research Applications[edit]
PSB-12062 is used in preclinical studies to elucidate the role of the A2B receptor in various physiological and pathological contexts. It serves as a valuable tool in pharmacological research to:
- Investigate the signaling pathways associated with A2B receptor activation.
- Explore the receptor's involvement in disease models.
- Develop new therapeutic strategies targeting the adenosine signaling system.
Safety and Toxicology[edit]
As a research chemical, PSB-12062 is not approved for human use. Its safety profile is primarily evaluated in laboratory settings, and it is handled according to standard safety protocols for chemical research.
Also see[edit]
- Adenosine receptor
- Adenosine A2A receptor
- Adenosine A1 receptor
- Adenosine A3 receptor
- G protein-coupled receptor
| Pharmacomodulation | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
